Magnetic Group Signaling (MGS®) standardizes NMR systems and sample processing to ensure reproducible results on different NMR instruments.
Using FDA-cleared technology, this is our core platform. It incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy. It's the first modular software-based system for clinical diagnostics.
Heart disease in the US
1. National Center for Health Statistics. Multiple Cause of Death 2018–2023 on CDC WONDER Database.
2. Palaniappan LP, , Allen NB, Almarzooq ZI, et al. 2026 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2026 Jan 21 Online ahead of print.
Our CE-marked AXINON® lipoFIT® assay provides more precise information than the standard cholesterol test.
It measures concentration, size and distribution of the lipoprotein particles that carry cholesterol, as well as the quantity of triglycerides, cholesterol and phospholipids.
Available as CE-marked IVD in the EU
Standard | Particle | Particle | Metabolites |
|---|---|---|---|
| Total cholesterol LDL cholesterol HDL cholesterol Triglycerides | LVLDL-p LDL-p SLDL-p HDL-p LHDL-p | VLDL-s LDL-s HDL-s | Alanine Valine Leucine Isoleucine |
More information on the AXINON® lipoFIT® test system
Nuclear magnetic resonance (NMR) spectroscopy is a proven and highly accurate test technology that assesses a variety of compounds at a molecular level.
Our AXINON® System, using FDA-cleared technology, is the core platform we use to develop diagnostic tests for illnesses stemming from metabolic dysfunction, including chronic heart, kidney and liver diseases.
This system incorporates diagnostic testing algorithms into nuclear magnetic resonance (NMR) spectroscopy for precise results.
To date, more than 3.5 million tests have been performed worldwide using Numares technology.
* For Research Use only in the United States. numares’ products are not yet available for sale within the United States; they have not yet been approved or cleared by the U.S. Food and Drug Administration.
